News and Reports
-
ChemoCentryx reports clinical efficacy for CCX354 in Phase II study in Rheumatoid Arthritis
8 November 2011Download -
Pacira announces FDA approval of Exparel for pain
31 October 2011Download -
Pacira Pharmaceuticals announces U.S. FDA approval of EXPAREL(TM) for postsurgical pain management
31 October 2011Download -
ChemoCentryx initiates Phase II clinical trial for CCX168, a novel small molecule C5aR antagonist for the treatment of Vasculitis
17 October 2011Download -
Enanta awarded up to $42.7 million niaid contract to develop a novel broad spectrum bicyclolide antibiotic
13 October 2011Download -
Nabriva Therapeutics presents extended Phase II results for Pleuromutilin Antibiotic BC-3781
15 September 2011Download -
mtm laboratories to be acquired by Roche
19 July 2011Download -
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
19 July 2011Download -
Delenex extends its A round to CHF 30.2 million
3 May 2011Download -
Anthera Pharmaceuticals successfully completes Interim Biomarker analysis of VISTA-16 study and third review of Varespladib Methyl
18 April 2011Download -
Mpex Pharmaceuticals, Inc. to be acquired by Axcan
14 April 2011Download -
HBM BioVentures: Successful sale of indirect holing in China Health System generates cash inflow of approximately USD 17 million
1 April 2011Download -
PTC Therapeutics appoints Robert Spiegel, M.D. as Chief Medical Officer
30 March 2011Download -
Pacira Pharmaceuticals, Inc. announces pricing of its Initial Public Offering
3 February 2011Download -
Valeant Pharmaceuticals to acquire PharmaSwis S.A.
1 February 2011Download -
Successful sale of HBM portfolio company PharmaSwiss to Valeant
1 February 2011Download -
HBM BioVentures realises a profit of EUR 41.9 million through the sale of PharmaSwiss to Valeant
1 February 2011Download -
MiCardia Corp.: Optimizing mitral valve repair
31 January 2011Download -
Nabriva reports positive results from phase II trial of Pleuromutilin antibiotic BC-3781 in ABSSSI
18 January 2011Download -
PTC Therapeutics completes enrollment of Phase 3 trial in Cystic Fibrosis
21 December 2010Download -
Vivacta closes £4 million financing
10 November 2010Download -
mtm laboratories extends series C financing round by EUR 7 million (USD 9.7 million)
8 November 2010Download -
MiCardia corporation receives CE mark clearance to market enCor dynamic mitral valve repair system in te European Union
3 November 2010Download -
Abbott and Enanta present positive initial results from phase 2 study in Hepatitis C
1 November 2010Download -
Pivotal data suggest PTC Therapeutics' Ataluren slows loss of walking ability in muscular distrophy patients
15 October 2010Download